# Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing

> **NCT01214811** · PHASE3 · COMPLETED · sponsor: **Molnlycke Health Care AB** · enrollment: 27 (actual)

## Conditions studied

- Inflammation
- Burns
- Ulcers

## Interventions

- **DEVICE:** Mepilex Border Ag

## Key facts

- **NCT ID:** NCT01214811
- **Lead sponsor:** Molnlycke Health Care AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2013-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01214811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01214811, "Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01214811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*